<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
KRTX
Karuna Therapeutics
$
()


  • Neurocrine price target raised by $6 at Piper Sandler, here's why

    2/8/2024 - 07:33am
  • Karuna Therapeutics just downgraded at Mizuho, here's why

    1/26/2024 - 04:50am
  • The biopharmaceuticals stocks to own in 2024, according to BofA

    1/3/2024 - 10:47am
  • Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited

    1/3/2024 - 06:12am
  • Karuna Therapeutics price target raised by $133 at UBS, here's why

    1/2/2024 - 06:26am
  • Karuna Therapeutics just downgraded at JPMorgan, here's why

    12/28/2023 - 04:51am
  • RayzeBio deal another 'incremental positive' for Bristol, says Morgan Stanley

    12/27/2023 - 07:59am
  • What You Missed On Wall Street On Tuesday

    12/26/2023 - 16:32pm
  • What You Missed On Wall Street This Morning

    12/26/2023 - 12:08pm
  • Karuna downgraded, Arm target raised: Wall Street's top analyst calls

    12/26/2023 - 10:04am
  • Karuna deal favorable for Axsome Therapeutics, says H.C. Wainwright

    12/26/2023 - 06:17am
  • Reviva may be most undervalued in neurology, says H.C. Wainwright

    12/26/2023 - 06:13am
  • Karuna Therapeutics just downgraded at H.C. Wainwright, here's why

    12/26/2023 - 06:06am
  • Karuna Therapeutics just downgraded at Wells Fargo, here's why

    12/22/2023 - 16:14pm
  • Karuna Therapeutics just downgraded at Leerink, here's why

    12/22/2023 - 16:12pm
dynamic_feed Breaking News